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The biotransformation efficiency of alkylmercurial compounds was studied in rat liver, kidneys, blood,
and brain after 2-week administration of methylmercuric chloride (MeHg) and ethylmercuric chloride
(EtHg) at doses of0.25 or 2.5 mg Hg/kg, alone or in combination with sodium selenite (Se) at a level of0.5
mg Se/kg. Simultaneously, the level of metallothioneinlike proteins (MTP) and endogenous copper (Cu)
was monitored in tissues of control rats and intoxicated rats.
Regardless ofthe dose, the highest concentrations of inorganic mercury from both the alkylmercurials
was found in the rat kidneys. Sodium selenite had a variable effect on the amount of inorganic mercury
liberated, depending on the organ and the molar ratio of Hg:Se administered.
A statistically significant increase in the levels of MTP and endogenous Cu, compared with control
group, was found only in the kidneys ofintoxicated rats. This increase was dependent on the concentration
of inorganic mercury liberated by biotransformation of alkylmercurials. The observed changes appeared
when the level of inorganic mercury exceeded 10,Ig Hg/g tissue and reached a plateau at about 40 ,ug Hg/g
tissue. In the presence of selenium the plateau of MTP and Cu levels were no oberved in the kidneys,
regardless of the amount of inorganic mercury liberated.
Introduction
Changes in the homeostasis ofessential elements, es-
pecially zinc and copper, bytoxicmetals have been stud-
ied from the standpoint ofunderstanding ofthe harmful
action ofthe metals on the organism (1,2). Disturbances
in the metabolism ofendogenous metals may be induced
in experimental animals by administration of cadmium
(3-17), nickel (3,18,19), silver (18,20-22), bismuth
(23,24), gold (25,27), tin(28), molybdenum (29), andboth
inorganic mercury (22,23,26,30-32) and methylmercury
(31).
In general, these changes occur in those tissues of
experimental animals in which increase in the level of
*Department ofToxicological Chemistry, Institute ofEnvironmen-
tal Research and Bioanalysis, Medical Academy ofL6dz, Narutowicza
120A, 90-145 L6dz, Poland.
metallothioneinlike proteins by toxic metals have been
noted previously (2,19,23,24). Studies ofthose proteins
revealed that they differ in the content of endogenous
metals depending on the organ in which the stimulation
took place. In the metallothioneinlike protein of the
kidneys, copper dominates as endogenous metal (23,33-
36) while in the liver this role is played by zinc
(25,36-39). In the rat, inorganic mercury stimulates the
formation of metallothionein in the kidneys (26,40-47).
On the other hand, stimulation of metallothionein by
alkyl mercurials, is still a controversial subject (48-50).
Anincreaseintheconcentrationofmetallothioneinlike
proteins, highly correlated with the level of inorganic
mercury, was observed afterprolonged exposure ofrats
to ethylmercuric chloride and methylmercuric Tano-
guanidine (48). It was also demonstrated that Me 03Hg
(49,51), methoxyethyl 203Hg (49) and Et203Hg (52) are
bound by low molecular weight proteins of the soluble
fraction of rat kidneys.BRZEZNICKA AND CHMIELNICKA
Liberation in vivo ofinorganic mercury from organic
compounds of this metal has been demonstrated by
many authors (50,53,54). The efficiency of biotransfor-
mation of methylmercurials in the rat as a function of
doseandtypeofexposure isstillamatterofcontroversy.
Moreover, only fragmentary data concerning biotrans-
formation ofethylmercury, another alkyl mercuric com-
pound dangerous to living organisms, are available in
the literature (55-58).
The presence of selenium inhibits the stimulation of
biosynthesis of metallothioneinlike proteins by inor-
ganic mercury (47,48,59-63). Our previous studies
(51,52) have dealt with the metabolism of methyl- and
ethylmercuric chloride in rats in the presence and
absence ofselenium. the present study was designed to
determine ifthere is arelationship between the amount
ofinorganicmercuryliberatedfromthesealkylmercurial
compounds in the presence and absence ofselenium and
the concentration of metallothionein proteins and
endogenous copper in some rat tissues.
Materials and Methods
The experiments were made on female Wistar rats of
body weight 150 to 250 g which were standard LSM
granules and allowed to drink tap water ad libitum.
Table 1 shows the pattern of experimental groups
employed, single doses of mercury and selenium ad-
ministered and molar ratios of these elements in ap-
propriate groups. Methylmercuric chloride (MeHg) and
ethylmercuric chloride (EtHg) (K & K Laboratories Inc.,
Plainview, NY, USA)in0.1% sodiumcarbonate (POCh,
Gliwice, Poland) were administered intragastrically
(seven times in a two-week period). Selenium (Se) was
given as an aqueous solution of Na2SeO3 (POCh, Gli-
wice, Poland), also intragastically, every day over a 14-
day period. At 24 hr after administration of the last
dose, the animals were sacrificed under ether narcosis
by heart puncture, and then the appropriate tissues
were isolated.
The content of metallothioneinlike proteins was de-
termined radiochemically according to Piotrowski et al.
(64) as modified by Zelazowski and Piotrowski (65). Me-
tallothionein isolated from horse kidney cortex accord-
nable 1. Groups of animals.
Mercury, Selenium, Molar ratio
Groupa Treatment mg/kg mg/kg Hg:Se
I MeHg 0,25
Ia MeHg + Se 0.25 0.5 1:10
II MeHg 2.50
IIa MeHg + Se 2.50 0.5 1:1
III EtHg 0.25
IlIa EtHg + Se 0.25 0.5 1:10
IV EtHg 2.50
IVa EtHg + Se 2.50 0.5 1:1
V Control
Va Control + Se 0.5
'Six animals in each group.
ing to a method similar to that described by Pulido et
al. (66) was used as a standard (67). The standard had
three -SH groups permilligram protein. Underthe con-
ditions employed, 1 mg of the standard protein bound
about 200 ,ug of mercury. The content of endogenous
copperwasdetermined byaspectrophotometric method
with zinc dibenzyldithiocarbamate after mineralization
of the tissues with a mixture of concentrated sulfuric
and perchloric acids (68).
The content of inorganic and organic mercury was
estimated by cold atomic spectroscopy accordingto Ma-
gos (69) in the modification of Balcerska et al. (70), by
use of equipment with a Handrey Relays mercury de-
tector(mercuryvaporconcentrationmeterTypeE3472).
Ceruloplasmin activity in blood serum was deter-
mined by the colorimetric method ofLehman et al. (71),
o-dianisidine being used as a substrate.
Results
The concentrations ofinorganic and organic mercury
in the kidneys, liver, brain and blood for MeHg and
EtHg are presented in lables 2 and 3, respectively. The
Table 2. Levels of inorganic and organic mercury in the kidneys,
liver, brain, and blood of rats poisoned for 2 weeks with
methylmercury chloride as functions of dose and of presence
of sodium selenite.
Tissue
Kidneys
Liver
Brain
Blood
Group
I
Ia
II
IIa
I
Ia
II
Ia
I
Ia
II
IIa
I
Ia
II
,ug Hg/g tissuea
Inorganic Hg Organic Hg
1.75 4.21
1.08-2.10 3.85-4.89
1.58 2.39
0.78-2.43 1.54-3.19
14.28 47.02
12.19-16.49 44.67-51.80
9.41 47.83
7.20-13.81 37.37-61.93
0.52 0.77
0.33-0.53 0.76-0.96
0.51 0.70
0.24-0.99 0.22-0.97
0.13 13.29
0.08-1.27 12.18-13.34
0.55-2.39 6.52-8.36
0.08
0.06-0.10
0.08
0.00-0.12
0.69
0.39-1.34
0.90
0.78-1.03
0.64
0.10-1.87
0.27
0.22-0.34
5.82
2.42-10.50
IIa 3.11
1.80-3.90
aMean values and ranges from six animals.
0.49
0.47-0.52
0.68
0.64-0.76
3.70
3.07-3.99
6.37
6.24-6.50
6.77
5.50-7.11
2.91
2.84-2.96
52.86
34.00-98.39
65.69
49.80-85.08
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Table 3. Levels of inorganic and organic mercury in the kidneys,
liver, brain, and blood of rats poisoned for 2 weeks with
ethylmercuric chloride as functions of dose and of presence
of sodium selenite.
jig Hg/g tissuea
Tissue Group Inorganic Hg Organic Hg
Kidneys III 33.05 14.73
28.81-37.14 10.51-20.28
IIIa 12.59 5.22
12.47-12.78 5.03-5.34
IV 73.48 29.80
58.11-91.86 11.41-45.17
IVa 97.76 73.43
71.81-128.66 42.53-99.38
Liver III 1.41 0.44
1.21-1.50 0.34-0.65
IIIa 2.25 0.87
2.17-2.33 0.71-1.03
IV 6.92 20.86
6.05-8.60 19.18-21.73
IVa 12.30 17.62
8.26-20.71 9.21-22.76
Brain
III 0.09 0.36
0.08-0.09 0.34-0.38
IIIa 0.35 1.02
0.30-0.41 0.77-1.23
IV 1.21 3.23
0.92-1.56 2.71-3.65
IVa 3.69 9.14
3.18-4.12 8.72-9.65
Blood III 3.83 3.06
3.26-4.36 2.53-3.64
IIIa 3.21 1.52
3.07-3.37 1.36-1.72
IV 36.14 56.04
28.66-42.93 46.64-66.39
IVa 24.16 40.02
20.57-36.60 27.58-43.61
aMean values and ranges from six animals.
percent contribution of the two forms of mercury
accumulating in these tissues after a 2 weeks exposure
to the alkylmercuric compounds and selenium is shown
in Figure 1.
The extent of biotransformation of the alkylmercu-
rials studied in the rat depends on the dose and tissue.
In the liver a high dose (2.5 mg Hg/kg) almost com-
pletely inhibits the capacity for dealkylation ofmethyl-
mercuric chloride. After 2-week poisoning of rats with
MeHg at doses of 0.25 mg Hg/kg (group I) and 2.5 mg
Hg/kg (group II), inorganic mercury liberated consti-
tuted about 40% and 1%, respectively, ofthe total mer-
cury incorporated in this tissue. On the other hand, in
the blood the differences in the extent of biotransfor-
mation as a function ofdose were much smaller than in
the liver(Fig. 1). The contribution ofinorganic mercury
to the total blood mercury after methylmercury intox-
ication ranged from 8 to 15% for doses of 0.25 and 2.5
mg Hg/kg, respectively. In the kidneys, the extent of
biotransformation of this compound was about 29% in
group I and about23% in group II (Fig. 1). Inthe brain,
the content of inorganic mercury after administration
ofmethylmercuric chloride at doses of0.25 and 2.5 mg
Hg/kg was 0.08 and 0.69 ,ug Hg/g tissue, respectively
(Table 2), which amounted to about 15% of the total
mercury accumulated in this tissue, irrespective of the
dose (Fig. 1).
Administration of selenite simultaneously with the
high dose ofmethylmercury (Table 2) resulted in a de-
crease ofthe total mercury content ofthe liver accom-
panied by an increased in the extent ofbiotransformation
to inorganic mercury, from about 1% in group II to
about 10% in group IIa (Fig. 1).
In the kidneys, selenium brought about a uniform
diminution ofconcentrations ofboth forms ofmercury,
irrespectively ofthe dose ofMeHg. On the other hand,
in the brain the total mercury concentration was con-
siderably augmented by selenium (Table 2), but effi-
ciency of biotransformation remained unchanged (Fig.
1).
Ethylmercuric chloride was biotransformed more ef-
ficiently than methylmercuric chloride in all rat tissues
studied. However, as in the case of MeHg (Table 2),
dealkylation ofEtHg in the liver was dependent on the
dose (Table 3). The amount of inorganic mercury lib-
erated afteradministration ofEtHgfor2weeksatdoses
of0.25 mg Hg/kg group (III) and 2.5 mg Hg/kg (group
IV) was about 77.1% and 24.0%, respectively, of the
total mercury accumulated in the liver (Fig. 1).No anal-
ogous dependence was found in the kidneys ofrats poi-
soned with ethylmercury, where inorganic mercury
amounted to about 70% oftotal mercury irrespective of
the dose administered (Fig. 1).
In the blood and brain of rats given ethylmercury,
the mean concentrations oftotal and inorganic mercury
increased proportionally to the dose (Table 3). The con-
tributionofinorganicmercurytothetotalconcentration
ofthe metal was high for both doses, from 23% (group
III) to about 35% (group IV) in the brain, and about
50% in the blood (Fig. 1).
In the presence of sodium selenite the amount of in-
organic mercury liberated from ethylmercuric chloride
in the liver increased slightly, from about 77% in group
III to about 83.0% in group IIIa and from about 25.0%
in group IV to about 41.0% in group IVa (Fig. 1), a
phenomenon similar to that observed for methylmer-
curic chloride. No significant effect of selenium on the
efficiency of biotransformation of EtHg was found in
the kidneys, brain, and blood (Fig. 1).
'l'he appearance ofinorganic mercury in some rat tis-
sues due to biotransformation of alkylmercurial com-
pounds (Fig. 1) prompted us to undertake studies ofthe
level of mercury-induced metallothioneinlike protains
(MTP) and concentration of endogenous copper. In the
kidneys, liver, brain, spleen, and blood of control rats
the level ofcopper was, respectively, 13.4, 4.4, 3.1, 1.9
,ugCu/g, and 2.0 ,ugCu/mL. The level of metallothi-
oneinlike proteins in kidney, liver, and brain ofcontrol
animals was respectively, 0.24, 0.09, and 0.07 mg MTP/
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FIGURE 1. Percent contributions of inorganic and organic mercury to the total concentration of this metal in rat kidneys, liver, brain and
blood after 2 weeks exposure to methyl-and ethylmercuric chloride with and without Se (mean values and range from six animals).
Table 4. Levels ofmetallothioneinlike proteins (mTP), endogenous copper (Cu) and inorganic mercury in the kidneys ofcontrol rats with
and without Se and of rats poisoned for 2 weeks with alkylmercurials.
Alkylmercurial MTP, Copper, Inorganic Hg,
Group treatment Se mg/g tissuea ,ug/g tissue ±g/g tissuea
I MeHg, 0.25 mgHg/kg No 0.25 ± 0.05 15.81 ± 4.66 1.75 ± 0.80
Ia MeHg, 0.25 mgHg/kg Yes 0.23 ± 0.03 12.50 ± 4.52 1.58 ± 0.40
II MeHg, 2.50 mgHg/kg No 0.51 ± 0.17* 20.00 ± 7.21* 14.28 ± 2.28
IIa MeHg, 2.50 mgHg/kg Yes 0.27 ± 0.23 14.98 ± 2.13 9.41 ± 2.52
III EtHg, 0.25 mgHg/kg No 0.70 ± 0.Olt 32.66 ± 1.87t 33.05 ± 3.32
Illa EtHg, 0.25 mgHg/kg + Se Yes 0.33 ± 0.03 20.91 ± 3.42* 12.67 ± 2.23
IV EtHg, 2.5 mgHg/kg No 0.68 ± 0.03t 33.73 ± 1.04k 69.97 ± 19.67
IVa EtHg, 2.5 mgHg/kg + Se Yes 0.67 ± 0.03k 39.08 ± 6.74t 97.76 ± 19.44
V (control) No 0.24 ± 0.09 13.44 ± 4.09 b
Va None (control) Yes 0.13 ± 0.01* 33.52 ± 15.52 b
'All values means ± SD.
bBelow the detectability level of the method (50 ng Hg/g tissue).
*Difference statistically significant, a = 0.05.
tDifference statistically significant at a = 0.001.
g tissue. A significant increase in the level of endoge-
nous Cu and metallothioneinlike proteins in the exam-
ined tissues of exposed animals as compared to control
ones was shown only in the kidneys (Table 4).
Changes in endogenous copper levels were not con-
nected with ceruloplasmin because no alterations ofits
activity were noted in the exposed rats as compared
with the control.
Sodium selenite adminstered simultaneously with
methylmercury (groups Ia and Ila) and the low dose of
ethylmercury (groups IIIa) decreased the concentration
ofthis protein in the kidneys as compared with the level
typical for animals exposed to alkylmercurials alone
(Table 4). Administration of only selenium (group Va)
alsodecreased aboutthe concentration oftheseproteins
in rat kidneys twofold as compared with the control
group (Table 4).
The changes in the level of metallothioneinlike pro-
teins in exposed animals were accompanied by an
statistically significant increase ofthe concentration of
endogenous copper (Table 4).
The concentration of copper in the kidneys was
normalized after combined administration of methyl-
mercury and selenium (Table 4). On the other hand,
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administration of ethylmercuric chloride elevated the
level of endogenous copper in the kidneys significantly
(Table 4), even in the presence ofan excess ofselenium
(groups IIIa).
The dependence of the level of metallothioneinlike
proteins and ofendogenous copperin rat kidneys on the
amount of inorganic mercury accumulated in these
organsaftera2-weekexposure is presented inFigure2.
It can be seen from these data that the increase of
values ofthe parameters studied wasparallel andbegan
when the concentration ofinorganic mercury liberated
from alkyl compounds by biotransformation exceeded
10 ,ug Hg/g tissue.
Discussion
Results of this study permit comparison of the effi-
ciency of biotransformation of methyl- and ethylmer-
curic chloride in rats including dose dependence. We
found that irrespective of the dose of methylmercury,
about 23 to 29% of inorganic mercury was liberated in
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ratkidneys(Fig. 1). Thisprocesswasaugmentedduring
prolonged exposure ofrats to alow dose ofMeHgwhen
liberated inorganic mercury amounted to 40% of total
mercury accumulated in this tissue (58). A similar ef-
ficiency ofthis process in rat kidneys was reported by
Klein et al. (72) after single administration of two dif-
ferent doses of methylmercury and by Norseth (73) as
well as Magos and Butler (74) after repeated exposure
of rats to this compound. It results even from the ex-
periments ofOmata et al. (50) employing a high dose of
MeHg (25 mg Hg/kg).
Afteradministration ofethylmercury, inorganicmer-
cury amounted to 70% oftotal mercury in the kidneys
of rats (Fig. 1). A similar efficiency of EtHg biotrans-
formationintheratskidneyswasmaintained evenwhen
the time ofexposure was prolonged (58).
Biotransformation of EtHg in the brain is also even
more efficient thanthat ofmethylmercury chloride, and
concentrations of both total and inorganic mercury in
the brain of animals poisoned with ethylmercury are
higherthan afterpoisoningwith the same dose ofmethyl-
mercury (Fig. 1).
In the ratbrain, inorganicmercury constituted about
t(25mH '/kg)
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2,;5mgHg/kg)
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FIGURES 2. Dependence ofthe levelsof-endogenous copper and-metallothioneinlike proteins in ratkidneys onthe concentration ofinorganic
mercury in kidney after 2 weeks exposure to various doses of methyl- and ethylmercuric chloride administered without or with sodium
selenite.
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15% of total mercury, irrespective of the dose MeHg
(Fig. 1). Asimilarefficiency ofmethylmercury biotrans-
formation in the brain was found by Mengel and Karlog
(49) after chronic exposure ofrats to this compound and
by Omata et al. (50) after single administration ofmethyl-
mercury 925 mg Hg/kg. On the other hand, Magos and
Butler (74) reported a considerably lower efficiency of
biotransformation of this compound in the rat brain,
probably due to the use of a very high cumulative dose,
close to LD5.
In the liver, biotransformation of methylmercury as
well as ethylmercury is closely related to the dose of
these compounds (Fig. 1). This process proceeds more
intensely at the lower dose when the contribution of
inorganic mercury to the total mercury content is about
40% and 77% for MeHg and EtHg, respectively. At
higher doses, the efficiency of biotransformation de-
creases to about 25% for ethylmercury and vanishes
almost completely for methylmercury (Fig. 1). A dim-
inution of the extent of mercury biotransformation in
the liver with increasing doses was also reported by
Norseth (73), Mengel and Karlog (49), and Magos and
Butler (74). It seems that, in contrast to the kidneys,
the liver is an organ very sensitive to the action of
alkylmercurials, and the microsomal fraction ofhepatic
cells is responsible for the diminution of the efficiency
of biotransformation with increasing doses of methyl-
mercury (and probably also ethylmercury). Results of
many studies (75-78) indicate that the biotransforma-
tion of methylmercuric compounds proceeds in the mi-
crosomal fraction of the liver by microsomal enzymes,
including cytochrome P-450. Depending on the doses of
methylmercury employed, some authors observed stim-
ulation (75,76) while others found inhibition of these
enzymes (77,78). It was also demonstrated that meth-
ylmercury given at high doses induces destruction of
endoplasmic reticulum ofliver cells (79), which may ex-
plaintheinhibition ofmethylmercury biotransformation
in the liver observed in this study.
Our results permit determination ofthe threshold level
ofaction ofinorganic mercury liberated from these alkyl
compounds on the level of metallothioneinlike proteins
and on disturbance ofhomeostasis ofendogenous copper
in some tissues. As we showed in our previous studies,
Hg binds to low molecular weight (metallothioneinlike)
protein fraction of the kidneys to a higher extent after
administration ofethylmercuric chloride (52) than after
methylmercuric chloride (51), which is due to the higher
efficiency of biotransformation of ethylmercury (58).
We observed changes in the levels ofmetallothionein
and endogenous copper (Table 4 and Fig. 2) when the
level ofinorganic mercury exceeded 10 ,ug Hg/g tissue.
This value can be assumed to be a threshold concentra-
tion for the phenomena in question. An increase in the
levels of metallothioneinlike proteins and endogenous
copperproceeded until the content ofinorganic mercury
reached 40 ,ug/g tissue (Fig. 2). Above this value, a
plateau was maintained for both MTP and Cu. Analo-
gous dependence was not observed in any other tissue,
probably since the amount of inorganic mercury liber-
ated there was much lowerthan 10 ptg Hg/gtissue. Only
in the liver was a tendency for increase ofthe levels of
both endogenous copper and metallothioneinlike pro-
teins seen after simultaneous administration of a high
dose of EtHg and Se when the level of inorganic
mercury liberated was about 12 ,ug Hg/g tissue
(Table 2), but these changes were devoid of statistical
significance.
The effect ofinteraction between the alkylmercurials
and sodium selenite (depends on the molar Hg:Se ratio)
is found to consist of a change of the distribution and
therefore ofconcentrations oftotal mercury (51,52) and
bothits formsinindividual tissues (Table 2and3). How-
ever, no significant differences in the percent contri-
butionofinorganicmercurytothetotalmercurycontent
in the tissues were found between animal groups poi-
soned with alkymercurials alone and those receiving
sodium selenite in addition to mercury (Fig. 1). It can
therefore be concluded that selenium does not accel-
erate the dealkylation ofalkylmercurials as it was sug-
gested for methylmercury by Yamane et al. (80).
Changes in the distribution of mercury by selenium
in rat tissues are apparently due to the binding by se-
lenium of inorganic mercury liberated from alkylmer-
curials by biotransformation and to alterations in the
tissue distribution ofmercury-selenium complexes as it
probably may be occurs in the case of interaction be-
tween inorganic mercury and selenium (81). This phe-
nomenon is expressed especially well in the case of
ethylmercuric chloride due to the high efficiency ofbio-
transformation of this compound to inorganic mercury
in vivo.
On the other hand, at low selenium concentrations in
the kidneys with respect to high concentrations of in-
organic mercury, an increase in the concentration of
mercury in this organ was observed (Table 3). A similar
phenomenon was noted by Burk et al. (61) in the case
of a high excess of inorganic mercury and by Mengel
and Karlog (82) as an effect of interaction between se-
lenium and a methoxyethylmercuric compound. Our
studiesindicatethataninteractioneffectbetweenethyl-
mercury and selenium leading to a decrease in the con-
centration of mercury in the kidneys occurs only at a
high excess ofselenium (group IIIa). Administration of
a slight excess ofthis element did not change the mer-
cury content of the kidneys (58), while an equimolar
dose, sufficient to induce redistribution of mercury in
the case ofexposure to an inorganic mercury compound
(56), not only did not decrease but even increased the
mercury concentration in this organ (Table 3). In the
presence of Se there are also changes in the amount of
'3Hg bound by low- molecular weight proteins of this
fraction the kidneys (51,52) accompanied by decreases
intheconcentrations ofmetallothioneinlikeproteins and
endogenous copper, probably due to the binding by se-
lenium ofinorganic mercuryliberated and probablyalso
ofother native metals. In this way their effects on the
homeostasis ofcopper and synthesis ofmetallothionein-
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Table 5. Ratios of kidney to brain total and inorganic mercury
concentrations as an index of neurotoxic potential.'
Kidney/brain Kidney/brain
total Hg ratio inorganic Hg
Treatment Se AsmaHgb By AASC (by ASSC)
MeHg, 0.25 mg Hg/kg No 9.66 10.28 21.87
MeHg, 2.50 mg Hg/kg No 9.44 14.03 20.69
EtHg, 0.25 mg Hg/kg No 145.90 129.13 367.22
EtHg, 2.50 mg Hg/kg No 15.78 23.26 60.73
MeHg, 0.25 mg Hg/kg Yes 2.77 6.54 19.75
MeHg, 2.50 mg Hg/kg Yes 4.34 7.87 10.45
EtHg, 0.25 mg Hg/kg Yes 7.72 13.00 35.97
EtHg, 2.50 mg Hg/kg Yes 16.64 13.34 26.49
'Ratios were calculated from tissue concentrations measured 24 hr
after 2-week exposure to methyl- or ethylmercuric chloride with and
without Se.
bDetermined as 203Hg (51,52).
'Determined by AAS according to Balcerska et al. (64).
like proteins are limited (Fig. 2).
On the other hand, the increase in the concentrations
of metallothioneinlike proteins and endogenous copper
in the kidneys ofrats given ethylmercury and an equi-
molar dose of selenium should be ascribed to the too
low amount of selenium with respect ot the amount of
inorganic mercury liberated in the kidneys from this
compound.
Alkylmercuric compounds havebothneuro-andneph-
rotoxic actions in the rat (72,83-85). The nephrotoxic
effect is ascribed to the effect ofinorganic mercury lib-
erated in the kidneys of these animals with a consid-
erable efficiency.
Magos (85) suggested that the ratio between the con-
centration of mercury in the kidneys and brain can be
used as an indicator of the neurotoxic potential. This
ratio is high for inorganic mercury and phenylmercury
(respectively about 102 and 83); and low for methyl-
mercury (about 4.5).
Table 5 shows numerical values ofthis coefficient cal-
culatedfromourdata. Theseresultsindicatethatvalues
Table 6. Ratios of brain to blood total and inorganic mercury
concentrations as an index of neurotoxic potential.'
Brain/blood
total Hg ratio Brain/blood
Treatment Se As "3Hgb By AASC inorganic Hgc
MeHg, 0.25 mg Hg/kg No 0.12 0.10 0.12
MeHg, 2.50 mg Hg/kg No 0.09 0.10 0.12
EtHg, 0.25 mg Hg/kg No 0.06 0.06 0.02
EtHg, 2.50 mg Hg/kg No 0.05 0.06 0.03
MeHg, 0.25 mg Hg/kg Yes 0.29 0.30 0.30
MeHg, 2.50 mg Hg/kg Yes 0.20 0.20 0.30
EtHg, 0.25 mg Hg/kg Yes 0.40 0.40 0.11
EtHg, 2.50 mg Hg/kg Yes 0.20 0.20 0.15
'Ratios were calculated from tissue concentrations measured 24 hr
after 2-week exposure to methyl- or ethylmercuric chloride with and
without Se.
bDetermined as 203Hg (51,52).
cDetermined by AAS according to Balcerska et al. (64).
of the neurotoxicity coefficients for various doses of
methylmercuric chloride are similar to these obtained
by Magos (85). Comparison of these values with those
for ethylmercuric chloride demonstrates a higher neu-
rotoxicity of methylmercury, in agreement with the
common view.
In the case of ethylmercuric chloride, however, nu-
merical values ofthis coefficient were dependent on the
dose (Table 5). Forthe low dose ofEtHg (group II) this
value was higher than that of the kidney/brain coeffi-
cient given by Magos (85) for MeHg, especially when
the concentration of inorganic mercury liberated from
ethylmercury in the kidneys and brain were taken into
account. This suggests that low doses of EtHg maybe
more nephrotoxic than HgCl2. The conclusion is in es-
sential disagreement with reports on the toxicity ofthese
compounds.
It seems that a coefficient calculated on the basis of
thebrain blood mercury concentration mightbeabetter
index of neurotoxicity, especially if concentrations of
inorganic mercury in both these tissues (Table 3) were
considered in the calculations. That value is the higher,
the more neurotoxic a given compound is (Table 6).
The presence of selenium, inducing the above de-
scribed changes inthe distributionofbothforms ofmer-
cury in the rat has a significant influence on values of
the discussed indices of neuro- and nephrotoxicity (Ta-
bles 5 and 6). These coefficients should be therefore
regarded with care and not employed for estimation of
the action of a mercuric compound when administered
simultaneously with selenium.
This work was performed within the framework ofProject MZ-IX,
Occupational Medicine, of the Ministry of Health, Polish People's
Republic.
We wish to thank Mrs. Honorata Debicka for excellent technical
assistance and for her help in the preparation of the figures.
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